Revolutionising Pain Management with Artificial Intelligence

Machine learning and artificial intelligence are transforming virtually every aspect of medicine. In pain management and orthopaedics, the impact has been slower to arrive — but at OPTM Healthcare, we have been deploying AI-assisted diagnostics since the mid-2000s, and the technology has reached a level of sophistication that genuinely changes what is possible in patient care.

Our AI system does three things that were previously impossible at scale:

Biomarker pattern recognition: The 14+ biomarkers in our diagnostic panel interact in complex, non-linear ways. A patient with elevated CRP plus low vitamin D plus high MMP-3 will respond very differently to phytomedicine than a patient with the same CRP level but different co-marker patterns. The AI engine, trained on 1.2 lakh+ patient cases, recognises these patterns with a nuance that exceeds what any individual clinician can hold in working memory.

Outcome prediction: Before treatment begins, our AI system predicts — with 89% accuracy — whether a patient will achieve Grade 1 improvement (significant pain reduction, full functional restoration), Grade 2 (meaningful improvement, partial restoration), or minimal response. This allows us to set accurate expectations with patients and adjust protocol intensity accordingly.

Protocol optimisation: The AI engine generates specific treatment recommendations — which phytomedicine compounds, at which concentrations, in which combination — based on the patient's biomarker profile. It also flags patients who are unlikely to respond to our standard protocol and recommends protocol modifications or alternative approaches.

The result is a diagnostic and treatment system that gets more precise over time as it learns from each new patient case. Every OPTM patient who gives consent for data use makes the AI smarter for the next patient.